Events7th International Electronic Conference on Medicinal Chemistry
Published
This submission belongs to the session S6. Round table on predictive tools of the event 7th International Electronic Conference on Medicinal Chemistry
Published date
03 Nov, 2021
Academic Editor
author-avatarJean Jacques Vanden Eynde
Citation
Jędrzej Kukułowicz, Marek Bajda, Structural studies on SCL6A15 neutral amino acid transporter , in Proceedings of 7th International Electronic Conference on Medicinal Chemistry, 1 November–30 November 2021, MDPI: Basel, Switzerland, doi: 10.3390/ECMC2021-11471
Share
Email
Facebook
Twitter
LinkedIn

Structural studies on SCL6A15 neutral amino acid transporter

1. Department of Physicochemical Drug Analysis, Faculty of Pharmacy, Jagiellonian University Medical College, Poland
2. Department of Physicochemical Drug Analysis, Faculty of Pharmacy, Jagiellonian University Medical College
Abstract

Transporters from the SLC6 family play many important physiological functions. They are responsible for transport of neurotransmitters, osmolytes or energy substrates thus they participate in the nerve signaling and maintaining cellular and organism homeostasis. Depending on the sequence identity SLC6 family is divided into 4 groups: monoamine transporters, GABA transporters, amino acid transporters group I, and transporters for amino acids group II named also orphan transporters (OTs). OTs include 6 proteins, products of genes SLC6A15-SLCA620, whose 3D structures still remain unsolved (with one exception - SLC6A19).Their primary physiological function is supplying cells with nutritional neutral amino acids throughout sodium coupled symport. SLC6A15 (alias B(0)AT2) is mainly expressed in central nervous system. It allows for the transport of proline, branched-chain amino acids or methionine from extracellular compartment to the cell. Studies showed evidence that impaired functioning of SLC6A15 can be associated with major depressive disorder, behavioral changes or obesity. Since significance of SLC6A15 in the course of mentioned illnesses was proved we conducted preliminary in silico investigation to construct spatial structure of mentioned transporter using homology modeling. Further, we made an attempt to provide principles of substrate selectivity and functioning of the transporter. Using solved structures of the transporters for serotonin, dopamine, leucine (SERT, DAT, LeuT) and SCL6A19 we generated reliable models of SLC6A15 and performed docking studies. Obtained results showed significant role of hydrophobic pocket and non-helical fragments of TM6 and TM1 for binding of substrates.

Keywords
SLC6
Amino acid transporters group II
SLC6A15
molecular modeling
homology models
Poster
ecmc_fin_jedrzej_kukulowicz.pdf
The inhibitory capacity of organometallic compounds with anticancer features in GST P1-1 enzyme activity: An automatic approach
Exploring effects of temperature on the catalytic site of non-structural protease 2 (nsP2) from Chikungunya virus by using molecular dynamics simulations and DFT calculations